| 11851434 |
Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors |
Steven W. Andrews, James F. Blake, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +2 more |
2023-12-26 |
| 11807649 |
Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2 |
Joseph P. Lyssikatos, Samuel Kintz, Qiang Su |
2023-11-07 |
| 11807638 |
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases |
Joseph P. Lyssikatos, Samuel Kintz |
2023-11-07 |
| 11802127 |
3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors |
Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Mark Laurence Boys, Joshua Ryan Dahlke +3 more |
2023-10-31 |
| 11767321 |
5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases |
Joseph P. Lyssikatos, Samuel Kintz |
2023-09-26 |
| 11691973 |
3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors |
Shelley Allen, Patrick Michael DOERNER BARBOUR, James F. Blake, Sydney Taylor BLANCHE, Mark Laurence Boys +9 more |
2023-07-04 |
| 11648243 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, James Collier +12 more |
2023-05-16 |
| 11634409 |
Compounds for the treatment of BRAF-associated diseases and disorders |
Patrick Barbour, Katie Keaton BROWN, Adam Cook, Erik James Hicken, Dean Russell Kahn +7 more |
2023-04-25 |
| 11603374 |
Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
James F. Blake, Donghua Dai, Julia Haas, Yutong Jiang, Gabrielle R. Kolakowski +6 more |
2023-03-14 |
